Lingjuan Chen

931 total citations
30 papers, 679 citations indexed

About

Lingjuan Chen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Lingjuan Chen has authored 30 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Lingjuan Chen's work include Lung Cancer Research Studies (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Virus-based gene therapy research (4 papers). Lingjuan Chen is often cited by papers focused on Lung Cancer Research Studies (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Virus-based gene therapy research (4 papers). Lingjuan Chen collaborates with scholars based in China, United States and Australia. Lingjuan Chen's co-authors include Ruiguang Zhang, Xiaorong Dong, Guang Xu, Jinghua Ren, Fan Tong, Wei Zhang, Yang Wang, Qin Zhou, Yu Hu and Chunhua Wei and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Lingjuan Chen

28 papers receiving 671 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingjuan Chen China 14 238 227 133 124 118 30 679
Sonia Vivet France 12 248 1.0× 356 1.6× 31 0.2× 113 0.9× 38 0.3× 16 702
Koichi Doi Japan 9 53 0.2× 262 1.2× 28 0.2× 86 0.7× 12 0.1× 52 643
Chun-Chin Chen United States 13 278 1.2× 560 2.5× 49 0.4× 160 1.3× 93 0.8× 18 861
Ali Hassanzadeh Iran 7 360 1.5× 158 0.7× 189 1.4× 18 0.1× 87 0.7× 12 543
Hongjun Su China 17 47 0.2× 338 1.5× 148 1.1× 98 0.8× 33 0.3× 32 799
Surya Murty United States 13 229 1.0× 231 1.0× 127 1.0× 84 0.7× 112 0.9× 25 825
Yuanfan Yang United States 10 147 0.6× 337 1.5× 104 0.8× 70 0.6× 44 0.4× 22 584
Mi-Ran Choi United States 11 134 0.6× 239 1.1× 89 0.7× 36 0.3× 65 0.6× 16 528
Myung‐Jeom Ryu South Korea 12 45 0.2× 239 1.1× 87 0.7× 179 1.4× 43 0.4× 22 597
Natalia Moreno Germany 14 126 0.5× 461 2.0× 93 0.7× 43 0.3× 51 0.4× 21 687

Countries citing papers authored by Lingjuan Chen

Since Specialization
Citations

This map shows the geographic impact of Lingjuan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingjuan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingjuan Chen more than expected).

Fields of papers citing papers by Lingjuan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingjuan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingjuan Chen. The network helps show where Lingjuan Chen may publish in the future.

Co-authorship network of co-authors of Lingjuan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Lingjuan Chen. A scholar is included among the top collaborators of Lingjuan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingjuan Chen. Lingjuan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Penghao, Ruizhi Wang, Yueting Jiang, et al.. (2025). Emergence of multidrug-resistant Candidozyma auris in southern China: a multicenter study on genetic diversity and antifungal resistance. Frontiers in Microbiology. 16. 1689176–1689176.
2.
Ye, Junjie, Lingjuan Chen, Chunyan Li, et al.. (2025). Oncolytic vaccinia virus expressing non-secreted decoy-resistant IL-18 mutein elicits potent antitumor effects with enhanced safety. PubMed. 33(3). 201022–201022. 1 indexed citations
3.
Liu, Lichao, Jian Wang, Ying Wang, et al.. (2024). Blocking the MIF-CD74 axis augments radiotherapy efficacy for brain metastasis in NSCLC via synergistically promoting microglia M1 polarization. Journal of Experimental & Clinical Cancer Research. 43(1). 128–128. 27 indexed citations
4.
Chen, Lingjuan, Xiaoying Wang, Jiahui Lu, et al.. (2024). Vision matters for shape representation: Evidence from sculpturing and drawing in the blind. Cortex. 174. 241–255. 2 indexed citations
5.
Chen, Lingjuan, Xiang Chen, Xiaohua Niu, & Xiaofei Peng. (2023). LncRNAs in colorectal cancer: Biomarkers to therapeutic targets. Clinica Chimica Acta. 543. 117305–117305. 10 indexed citations
6.
Chen, Lingjuan, et al.. (2023). Oncolytic virotherapy in cancer treatment: challenges and optimization prospects. Frontiers in Immunology. 14. 1308890–1308890. 49 indexed citations
7.
Chen, Lingjuan, et al.. (2023). Radiation therapy in the era of immune treatment for hepatocellular carcinoma. Frontiers in Immunology. 14. 1100079–1100079. 12 indexed citations
8.
Chen, Xiang, et al.. (2023). Anti-PD-1/PD-L1 therapy for colorectal cancer: Clinical implications and future considerations. Translational Oncology. 40. 101851–101851. 37 indexed citations
9.
Chen, Lingjuan, Fang Tong, Ling Peng, et al.. (2022). Efficacy and safety of recombinant human endostatin combined with whole-brain radiation therapy in patients with brain metastases from non-small cell lung cancer. Radiotherapy and Oncology. 174. 44–51. 8 indexed citations
10.
Liu, Lichao, et al.. (2022). Case report: A rare case of neutropenia caused by pembrolizumab in squamous lung cancer and literature review. Frontiers in Oncology. 12. 973421–973421. 3 indexed citations
11.
Peng, Xiaofei, et al.. (2021). Targeting epigenetics and lncRNAs in liver disease: From mechanisms to therapeutics. Pharmacological Research. 172. 105846–105846. 12 indexed citations
12.
13.
Wen, Lu, et al.. (2021). The Research Progress of PD-1/PD-L1 Inhibitors Enhancing Radiotherapy Efficacy. Frontiers in Oncology. 11. 799957–799957. 16 indexed citations
14.
Huang, Yu, Ying Wang, Lingjuan Chen, et al.. (2019). The influence of pemetrexed-based continuous maintenance therapy on survival of locally advanced and metastatic lung adenocarcinoma. Annals of Translational Medicine. 7(20). 524–524. 3 indexed citations
15.
Wei, Chunhua, Xiaomin Dong, Hui Lü, et al.. (2019). LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway. Journal of Experimental & Clinical Cancer Research. 38(1). 95–95. 113 indexed citations
16.
Chen, Lingjuan, Ruiguang Zhang, Dandan Yu, Gang Wu, & Xiaorong Dong. (2019). Shenqi Fuzheng Injection Ameliorates Radiation-induced Brain Injury. Current Medical Science. 39(6). 965–971. 9 indexed citations
17.
Zhang, Wei, Guang Xu, Lingjuan Chen, et al.. (2017). Enhanced hydrogen storage performances of LiBH4 modified with three-dimensional porous fluorinated graphene. International Journal of Hydrogen Energy. 42(22). 15262–15270. 22 indexed citations
18.
Zhang, Ruiguang, Yan Li, Zhongliang Wang, et al.. (2015). Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis. Tumor Biology. 36(11). 8585–8592. 33 indexed citations
19.
Chen, Lingjuan, et al.. (2014). Peripheral T-cell lymphoma complicated by immunoglobulin A pemphigus: A case report and literature review. Oncology Letters. 8(1). 62–66. 4 indexed citations
20.
Chen, Lingjuan, et al.. (2013). [Genotypes of Toxoplasma gondii isolates from HIV positive patients in Yunnan Province].. PubMed. 31(5). 410–1. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026